Efforts to find treatments that slow or prevent Alzheimer’s disease are making good progress, but the complexities of tackling the illness are making it difficult to estimate what impact they will have on future mortality rates. A…
Our Newsletter
Latest News
Latest Issue
Fitch Ratings has a ‘neutral’ outlook for North American life insurers for 2026 despite a more challenging backdrop.
Greg Winterton caught up with Dr. Joshua Funder, CEO and Managing Director of Household Capital, to discuss the current state of and outlook for the reverse mortgage sector of the Australian securitisation market in this month’s Q&A.
The Longevity & Mortality Investor Conference 2026 will be held in London, UK, on Tuesday, May 19th, 2026.





























